The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Spectral speech features may serve as noninvasive biomarkers for monitoring attention and executive function in major depressive disorder.

A set of 6 distinct midlife depressive symptoms appear to be associated with an increased risk for dementia later in life.

Having an opioid prescription at follow-up was associated with fewer symptoms of generalized anxiety disorder. Daily opioid use is associated with fewer generalized anxiety symptoms and lower odds of ...

HealthDay News — In multisociety guidance published in the November issue of Infection Control & Hospital Epidemiology, recommendations are presented for infection prevention and control (IPC) in the ...

At 57%, over half of nurses reported that virtual nursing programs did not reduce their workload, and among these, 10% said virtual nursing programs increased their workload. HealthDay News — Virtual ...